Findings reveal an association between podocyte dysfunction and glomerular immune abnormalities and suggest a potential role of vesicular trafficking defects in immune dysregulation during proteinuric kidney disease.
Abstract
Background Podocytes are indispensable for maintaining glomerular filtration barrier integrity and immune homeostasis. Although vacuolar protein sorting 34 (Vps34), a class III phosphoinositide 3-kinase, orchestrates intracellular membrane trafficking, its roles in glomerular immune regulation remain incompletely defined. This study identifies a critical link between podocyte-specific Vps34 dysfunction and glomerular immune injury, characterized by pronounced mesangial IgA deposition. Methods A podocyte-selective Vps34 knockout mouse model was generated. Kidney architecture and function were systematically assessed using histological, immunofluorescent, and ultrastructural analyses. Systemic immunoglobulin concentrations were measured, and bulk renal transcriptomics were conducted to delineate molecular alterations. Results Selective deletion of Vps34 in podocytes induced rapid-onset proteinuria from three weeks of age, progressive renal failure, and early mortality (median survival nine weeks). These mice exhibited marked mesangial expansion, focal and global glomerulosclerosis, and widespread foot process effacement. Immunofluorescence revealed intense mesangial IgA deposition, accompanied by elevated serum IgA and IgM and reduced IgG levels. Comprehensive transcriptomic profiling revealed progressive immune-related transcriptional changes, highlighting upregulation of antigen presentation, B cell activation, cytokine signaling, and extracellular matrix remodeling. In addition, Vps34 deficiency was associated with increased expression of DAMP-associated and inflammasome-related genes, suggesting engagement of inflammation-related transcriptional programs within the injured kidney. Conclusions Podocyte-specific Vps34 deficiency leads to progressive podocyte injury accompanied by IgA-dominant immune-complex deposition and immune-related changes in the kidney. These findings reveal an association between podocyte dysfunction and glomerular immune abnormalities and suggest a potential role of vesicular trafficking defects in immune dysregulation during proteinuric kidney disease.
The podocyte is a terminally differentiated cell whose foot processes and slit diaphragm form the final layer of the glomerular filtration barrier. Because podocytes are not effectively replaced after birth, and nephron number is fixed before it, their cumulative loss converts congenital and steroid-resistant nephrotic...
Petar Todorović, Andrea Kopilaš, Anita Racetin et al.· Life· 0 citations
BACKGROUND
Obesity-related glomerulopathy is increasingly common, yet its pathogenesis remains poorly understood. This study aimed to elucidate the mechanisms by which nonspecific glomerular IgG deposition promotes podocyte senescence in obesity-related glomerulopathy, thereby expanding potential therapeutic options....
Zi-Kang Liu, Bin-bin Dai, Yuxuan Jin et al.· Journal of the American Soci...· 0 citations
A genetically defined, multi‐hit mouse model that recapitulates the sustained hyperuricemia, metabolic dysregulation, and progressive fibrosis of human disease is established and glutathione peroxidase 3 (GPX3) is identified as a master regulator restraining precursor cell differentiation into Profib PT cells.
Yun-Fei Qi, Qiang Zhao, Lve Yue et al.· Advancement of science· 0 citations
Current evidence favors a multi-layer network perspective in which glomerular proteinuria reflects a breakdown of coordinated podocyte homeostasis across interconnected cellular compartments.
Mei-Jia Fu, Jia-Yi Lin, Cong Wang et al.· Frontiers in Genetics· 0 citations
Introduction and aim Immune-mediated nephropathies are a mechanistically diverse group of kidney disorders in which dysregulated innate and adaptive immunity drive sustained inflammation, tissue injury, and progressive fibrosis. The kidney is not a passive target of these processes but an active immunological organ, wh...
Xiao-Ming Wang· Frontiers in Cell and Develo...· 0 citations
This review synthesizes current understanding of disease mechanisms, molecular profiling evidence, biomarker candidates, and mechanism-directed therapies corresponding to each tissue injury program and delineates the design requirements for prospective biomarker-stratified trials essential to validating molecularly gui...
Jun Zhou, Wei Xiao, Hui Jian· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.